The global digital therapeutics market encompasses technology-based interventions treating medical conditions. Utilizing digital platforms, these solutions deliver evidence-based therapeutic interventions, leveraging software to engage patients and modify behavior. Digital therapeutics encompass a broad spectrum, including mobile apps, wearable devices, and online platforms, targeting conditions such as diabetes, mental health disorders, and respiratory diseases. With ongoing developments in telemedicine and healthcare technology, the global digital therapeutics market continues to evolve, addressing diverse healthcare challenges.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-digital-therapeutics-market
Data Bridge Market Research analyses that the Global Digital Therapeutics Market which was USD 4,300.00 million in 2022, is expected to reach USD 20,421.08 million by 2030, and is expected to undergo a CAGR of 21.5% during the forecast period 2023-2030. Remote patient monitoring, facilitated by digital therapeutics, enables healthcare providers to track and manage patients' health conditions beyond traditional settings. This growing adoption enhances real-time monitoring, promotes proactive intervention, and contributes to improved patient outcomes by providing continuous, remote healthcare support.
Key Findings of the Study
Telehealth expansion is expected to drive the market's growth rate
The widespread adoption of telehealth services and the ongoing digitalization of healthcare systems contribute to the seamless integration and acceptance of digital therapeutics into routine medical practices. Telehealth expansion facilitates the delivery of remote healthcare services, making it easier for patients to access digital therapeutics, fostering a more patient-centric approach to healthcare delivery, and enhancing the overall efficiency and effectiveness of medical interventions.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2023 to 2030
|
Base Year
|
2022
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Product Type (Software and Devices), Sales Channel (B2C and B2B), Application (Preventive Applications and Treatment/Care-related Applications)
|
Countries Covered
|
U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, Egypt, and Rest of Middle East and Africa
|
Market Players Covered
|
Omada Health, Inc. (U.S.), ResMed (U.S.), Pear Therapeutics, Inc. (U.S.), Solera Network (U.S.), Akili Interactive Labs, Inc. (U.S.), Better Therapeutics, LLC (U.S.), Biofourmis (U.S.), Click Therapeutics, Inc. (U.S.), Naturalcycles Nordic AB (Sweden), NuvoAir AB (Sweden), Welldoc’s Bluestar (U.S.), Happify, Inc. (U.S.), Limbix Health, Inc. (U.S.), Voluntis (U.S.), Xealth (U.S.)
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global digital therapeutics market is segmented on the basis of product type, sales channel, and application.
- On the basis of product type, the global digital therapeutics market is segmented into software and devices
- On the basis of sales channel, the global digital therapeutics market is segmented into B2C and B2B
- On the basis of application, the global digital therapeutics market is segmented into preventive applications and treatment/care-related applications
Major Players
Data Bridge Market Research recognizes the following companies as the major global digital therapeutics market players in global digital therapeutics market are Biofourmis (U.S.), Click Therapeutics, Inc. (U.S.), Naturalcycles Nordic AB (Sweden), NuvoAir AB (Sweden), Welldoc’s Bluestar (U.S.), Happify, Inc. (U.S.), Limbix Health, Inc. (U.S.), Voluntis (U.S.), Xealth (U.S.)
Market Developments
- In February 2022, Biofourmis unveiled Biofourmis Care, a tech-driven care management service for chronic condition patients. Integrating automated medication management, empowers care teams to remotely fine-tune medications for personalized therapy. This strategic initiative has enhanced health outcomes and curtailed overall patient care costs. Biofourmis' innovative approach positions it as a key player, contributing significantly to industry revenue while advancing the trajectory of remote care in the healthcare market
- In December 2021, Teladoc extended its partnership with the National Labour Alliance, broadening its virtual care offerings. The expanded agreement encompassed a comprehensive range of services, including specialty care, general medical consultations, expert medical services, mental health support, virtual primary care programs, and chronic disease management. This collaboration aimed to provide a diverse and extensive suite of virtual healthcare solutions to cater to a wide spectrum of healthcare needs for the National Labour Alliance and its members
- 2021 年 3 月，Pear Therapeutics Inc. 與塔夫茨健康計畫旗下領先的成癮治療提供者 Spectrum Health Systems 合作。此次合作旨在促進物質使用疾患的治療途徑和護理創新。透過結合 Pear Therapeutics 的數位療法、Spectrum Health Systems 的成癮治療專業知識以及塔夫茨健康計劃的廣泛影響力和資源，這一聯盟有望顯著影響成癮患者的生活，標誌著解決物質使用障礙帶來的挑戰的關鍵一步
- 2020 年 10 月，Livongo 與 Guidewell Mutual Holding Corporation 建立策略夥伴關係，Livongo 由此可以接觸到 Guidewell 的精選會員。此次合作使 Livongo 能夠將其全面的虛擬護理體驗擴展到患有糖尿病的 Guidewell 消費者。 Livongo 利用連網設備、先進的資料科學和遠距醫療，旨在改善這些會員的醫療保健體驗，提供端到端的解決方案。這項策略性舉措可望擴大 Livongo 的客戶群並鞏固其在醫療技術市場的地位
區域分析
從地理上看，全球數位治療市場報告涵蓋的國家包括美國、加拿大、墨西哥、秘魯、巴西、阿根廷、南美洲其他地區、德國、義大利、英國、法國、西班牙、荷蘭、比利時、瑞士、土耳其、俄羅斯、匈牙利、立陶宛、奧地利、愛爾蘭、挪威、波蘭、歐洲其他地區、日本、中國、印度、韓國、澳洲、新加坡、美國、泰國、菲律賓、菲律賓、其他地區、其他地區、日本、越南、其他國家科威特地區科威特、英國、英國、泰國、菲律賓、菲律賓地區
根據 Data Bridge 市場研究分析：
2023-2030 年預測期內，北美是全球數位治療市場的主導地區
北美憑藉強大的醫療保健基礎設施、主要行業參與者的集中以及廣泛的醫療保健設施在全球數位治療市場佔據主導地位。該地區先進的醫療保健體系，加上大量患有慢性疾病的人口，使其成為數位治療解決方案的重要中心。強大的醫療資源和技術進步基礎進一步鞏固了北美在推動數位治療市場成長和創新方面的領導地位。
預計在 2023-2030 年預測期內，亞太地區將成為全球數位治療市場成長最快的地區
預計亞太地區將在 2023 年至 2030 年期間主導全球數位治療市場。這一增長歸因於政府加強醫療保健措施、提高健康意識以及對管理慢性疾病的先進醫療技術的需求不斷增長。該地區龐大的人口和對優質醫療保健不斷增長的需求進一步促進了預測期內亞太地區數位治療市場的大幅擴張。
有關全球數位治療市場 報告的更多詳細信息，請點擊此處 - https://www.databridgemarketresearch.com/reports/global-digital-therapeutics-market
